Overall, small molecule inhibitors that block NOD1 or NOD2 signaling could be used to treat diseases characterized by excessive inflammation; on the other hand, NOD1 or NOD2 agonists could be employed to enhance the immune response against certain infections or even in cancer therapy to boost anti-tumor immunity. This evidence concerns the gene NOD2 and neoplasm.